Titan Pharmaceuticals
TTNP
#11035
Rank
C$8.56 M
Marketcap
C$6.44
Share price
-3.76%
Change (1 day)
16.05%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -C$3.92 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$6.58 Million, an increase over its 2023 earnings that were of -C$7.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$3.92 Million-40.49%
2024 -C$6.58 Million-15.5%
2023 -C$7.79 Million-45.43%
2022 -C$14.27 Million16.29%
2021 -C$12.27 Million-907.36%
2020 C$1.51 M-106.6%
2019 -C$23 Million82.4%
2018 -C$12.61 Million-36.93%
2017 -C$20 Million-378.62%
2016 C$7.17 M-145.53%
2015 -C$15.77 Million369.37%
2014 -C$3.36 Million-125.9%
2013 C$12.96 M-177.74%
2012 -C$16.68 Million13.59%
2011 -C$14.69 Million74.37%
2010 -C$8.42 Million3.61%
2009 -C$8.13 Million
2007 -C$25.76 Million12.08%
2006 -C$22.99 Million-28.65%
2005 -C$32.21 Million-10.03%
2004 -C$35.81 Million-6.08%
2003 -C$38.12 Million-14.76%
2002 -C$44.72 Million32.52%
2001 -C$33.75 Million27.55%
2000 -C$26.46 Million62.5%
1999 -C$16.29 Million4.04%
1998 -C$15.65 Million49.33%
1997 -C$10.48 Million-27.88%
1996 -C$14.54 Million13.04%
1995 -C$12.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.62 B-934,431.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$21.68 B-553,468.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-C$0.26 Billion 6,519.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$0.10 B-2,748.84%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-C$15.02 Million 283.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.46 Billion 11,515.97%๐Ÿ‡บ๐Ÿ‡ธ USA